Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Tonix Pharmaceuticals
TNXP
$205M
| – | – |
0
| – | – |
|
|
SIEN
2977
DELISTED
Sientra, Inc.
SIEN
| $224K | ﹤0.01% |
+2,660
| New | +$234K |
|
|
PBBI
2978
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
| $222K | ﹤0.01% |
21,800
+11,300
| +108% | +$117K |
|
2979
Bio-Rad Laboratories Class B
BIO.B
| $220K | ﹤0.01% |
1,100
| – | – |
|
2980
Intellicheck
IDN
$74.7M
| $220K | ﹤0.01% |
84,400
-19,800
| -19% | -$52.3K |
|
|
SOFO
2981
DELISTED
Sonic Foundry, Inc. Common Stock
SOFO
| $219K | ﹤0.01% |
43,919
+100
| +0.2% | +$483 |
|
|
TISA
2982
DELISTED
TOP Image Systems Ltd
TISA
| $219K | ﹤0.01% |
164,600
+1,200
| +0.7% | +$1.69K |
|
|
ABAC
2983
DELISTED
Renmin Tianli Group, Inc. Common Shares
ABAC
| $218K | ﹤0.01% |
94,576
+12,401
| +15% | +$38.2K |
|
2984
Smith Micro Software
SMSI
$17M
| $217K | ﹤0.01% |
5,821
-582
| -9% | -$33.3K |
|
2985
Boot Barn
BOOT
$4.87B
| $216K | ﹤0.01% |
21,800
-34,200
| -61% | -$370K |
|
|
CRTN
2986
DELISTED
Cartesian, Inc.
CRTN
| $213K | ﹤0.01% |
256,580
+61,900
| +32% | +$69.6K |
|
|
AIFC
2987
AI Financial Corp
AIFC
$58.6M
| $212K | ﹤0.01% |
40,080
+2,900
| +8% | +$16.1K |
|
|
RMGN
2988
DELISTED
RMG Networks Holding Corporation
RMGN
| $210K | ﹤0.01% |
66,775
+1,150
| +2% | +$3.55K |
|
|
SMIT
2989
DELISTED
Schmitt Industries Inc
SMIT
| $208K | ﹤0.01% |
129,800
-400
| -0.3% | -$645 |
|
2990
Lightpath Technologies
LPTH
$862M
| $207K | ﹤0.01% |
75,500
-32,400
| -30% | -$66.5K |
|
2991
Paramount Gold Nevada
PZG
$130M
| $206K | ﹤0.01% |
123,300
-300
| -0.2% | -$535 |
|
2992
InfuSystem Holdings
INFU
$244M
| $204K | ﹤0.01% |
88,600
-7,900
| -8% | -$18K |
|
|
FCE.B
2993
DELISTED
Forest City Realty Trust, Inc.
FCE.B
| $201K | ﹤0.01% |
+7,100
| New | +$203K |
|
2994
Tandem Diabetes Care
TNDM
$1.63B
| $200K | ﹤0.01% |
16,640
-13,800
| -45% | -$302K |
|
2995
SemiLEDS
LEDS
$19.9M
| $199K | ﹤0.01% |
62,570
-23,600
| -27% | -$76.9K |
|
|
SIFY
2996
Sify Technologies
SIFY
$1.14B
| $199K | ﹤0.01% |
36,917
-16,416
| -31% | -$86.9K |
|
2997
American Realty Investors
ARL
$243M
| $198K | ﹤0.01% |
24,600
+2,700
| +12% | +$19.3K |
|
|
TLGT
2998
DELISTED
Teligent, Inc
TLGT
| $198K | ﹤0.01% |
+2,534
| New | +$183K |
|
2999
Quest Resource Holding
QRHC
$30M
| $195K | ﹤0.01% |
83,151
+17,700
| +27% | +$40.6K |
|
|
RGLS
3000
DELISTED
Regulus Therapeutics
RGLS
| $195K | ﹤0.01% |
986
-1,691
| -63% | -$322K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.